FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Hospira 0.9% Sodium Chloride Injection Recall

0.9% Sodium Chloride Injection, USP, 100 mL ADD-Vantage Unit, Rx only, Manufactured by…

Hospira Inc. · Lake Forest, IL

Risk level
Class II
Reported by FDA
Apr 29, 2015
Recall ID
D-0490-2015
Check your lot numberHow we source this data

Summary

Hospira recalled 0.9% Sodium Chloride Injection starting Apr 7, 2015. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0490-2015 on Apr 29, 2015. Reason: Lack of Sterility Assurance: The product has the potential to leak at the administrative port. Status: Terminated.

Why it was recalled

Lack of Sterility Assurance: The product has the potential to leak at the administrative port.

Product description

0.9% Sodium Chloride Injection, USP, 100 mL ADD-Vantage Unit, Rx only, Manufactured by Hospira Inc., Lake Forest, IL, 60045, NDC: 0409-7101-67

Lot numbers, UPCs & expiration codes

Lot# 44-110-JT; Exp 08/16

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0490-2015
Classification
Class II
Status
Terminated
Recall initiated
Apr 7, 2015
FDA report date
Apr 29, 2015
Quantity
128,050 ADD-Vantage flexible containers
Recall type
Voluntary: Firm initiated
Recalling firm
Hospira Inc.

Original FDA data

Every field from FDA enforcement report D-0490-2015, exactly as published.

Show all FDA fields
City
Lake Forest
State
IL
Status
Terminated
Country
United States
Event ID
70925
Address
600 N Field Dr
Code information
Lot# 44-110-JT; Exp 08/16
Postal code
60045-4835
Report date
Apr 29, 2015
Product type
Drugs
Recall number
D-0490-2015
Classification
Class II
Recalling firm
Hospira Inc.
Product quantity
128,050 ADD-Vantage flexible containers
Termination date
Nov 4, 2016
Reason for recall
Lack of Sterility Assurance: The product has the potential to leak at the administrative port.
Voluntary / mandated
Voluntary: Firm initiated
Product description
0.9% Sodium Chloride Injection, USP, 100 mL ADD-Vantage Unit, Rx only, Manufactured by Hospira Inc., Lake Forest, IL, 60045, NDC: 0409-7101-67
Distribution pattern
Nationwide
Recall initiation date
Apr 7, 2015
Initial firm notification
Letter
Center classification date
Apr 17, 2015

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0490-2015, published Apr 29, 2015. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls